Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1035105 | 0.87 | CYP3A4 (0.40) | CYP3A4 | |
| SCHEMBL9181823 | 0.83 | CYP3A4 (0.40) | CYP3A4 | |
| SCHEMBL11767099 | 0.80 | CYP3A4 (0.42) | CYP3A4 | |
| SCHEMBL11761677 | 0.80 | CYP3A4 (0.38) | CYP3A4 | |
| SCHEMBL3517726 | 0.79 | KCNN4 (0.36) | — | |
| SCHEMBL5576974 | 0.78 | CYP3A4 (0.45) | CYP3A4 | |
| SCHEMBL10959911 | 0.76 | CYP3A4 (0.39) | CYP3A4 | |
| SCHEMBL6704455 | 0.75 | CYP3A4 (0.47) | CYP3A4 | |
| SCHEMBL17966617 | 0.75 | CYP3A4 (0.42) | CYP3A4 | |
| SCHEMBL3611392 | 0.75 | CYP3A4 (0.42) | CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024083887-A1 | FREE-RADICAL POLYMERISATION OF UV-CROSSLINKING SILANE ACRYLATES IN AN ISOCYANATE-CONTAINING POLYURETHANE MATRIX | FOLLMANN GMBH & CO. KG (DE) | 2024-04-25 | — | — | WO | claimed |
| EP-4326795-A1 | POLYMERIZATION OF A SILANE-MODIFIED POLYMER, WHICH IS PRODUCED BY MEANS OF A RADICAL CHAIN POLYMERIZATION, IN A POLYOL OR IN A PREPOLYMER WITH TERMINAL ISOCYANATE GROUPS, AND USE THEREOF IN POLYURETHANE FORMULATIONS | Follmann GmbH & Co. KG (DE) | 2024-02-28 | — | — | EP | claimed |
| US-12227531-B2 | Silylated organomodified compounds | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2025-02-18 | — | — | US | disclosed |
| EP-4405366-A1 | SILYLATED ORGANOMODIFIED COMPOUNDS | Momentive Performance Materials Inc. (US) | 2024-07-31 | — | — | EP | disclosed |
| CN-118339170-A | Silylated organomodified compounds | 迈图高新材料公司 | 2024-07-12 | — | — | CN | disclosed |
| WO-2024083887-A1 | FREE-RADICAL POLYMERISATION OF UV-CROSSLINKING SILANE ACRYLATES IN AN ISOCYANATE-CONTAINING POLYURETHANE MATRIX | FOLLMANN GMBH & CO. KG (DE) | 2024-04-25 | — | — | WO | disclosed |
| EP-4326795-A1 | POLYMERIZATION OF A SILANE-MODIFIED POLYMER, WHICH IS PRODUCED BY MEANS OF A RADICAL CHAIN POLYMERIZATION, IN A POLYOL OR IN A PREPOLYMER WITH TERMINAL ISOCYANATE GROUPS, AND USE THEREOF IN POLYURETHANE FORMULATIONS | Follmann GmbH & Co. KG (DE) | 2024-02-28 | — | — | EP | disclosed |
| WO-2023096809-A1 | SILYLATED ORGANOMODIFIED COMPOUNDS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2023-06-01 | — | — | WO | disclosed |
| US-20230159571-A1 | SILYLATED ORGANOMODIFIED COMPOUNDS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12227531-B2 | Silylated organomodified compounds | SHBG, NR5A1, CYP19A1 | CYP3A4 246/4885 |
| US-20230159571-A1 | SILYLATED ORGANOMODIFIED COMPOUNDS | SHBG, NR5A1, CYP19A1 | CYP3A4 246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.